Celularity Stock In The News

CELU Stock  USD 2.76  0.09  3.16%   
Our overall analysis of Celularity's news coverage and content from conventional and social sources shows investors' bearish mood towards Celularity. The specific impact of Celularity news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Celularity's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Celularity headlines in addition to utilizing other, more conventional financial analysis modules. Check out Celularity Backtesting and Celularity Hype Analysis.
For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.

Celularity Today Top News and Investor Outlook

Yahoo News
15 Best Falling Stocks To Buy Now
https://finance.yahoo.com/news/15-best-falling-stocks-buy-160700921.html
 Neutral
Macroaxis News: globenewswire.com
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
https://www.globenewswire.com/news-release/2023/11/24/2785689/0/en/Celularity-Inc-Announces-Receipt-of-Nasdaq-Notice-Regarding-Late-Form-10-Q-Filing.html
 Neutral
Macroaxis News: globenewswire.com
Celularity Announces Commercial Biomaterial Products Receive Saudi Food and Drug Authority (SFDA) Product Classification
https://www.globenewswire.com/news-release/2023/10/18/2762428/0/en/Celularity-Announces-Commercial-Biomaterial-Products-Receive-Saudi-Food-and-Drug-Authority-SFDA-Product-Classification.html
 Neutral
Macroaxis News: globenewswire.com
Celularity Appoints Geoffrey Shiu Fei Ling, M.D., Ph.D. to its Board of Directors
https://www.globenewswire.com/news-release/2023/09/07/2739783/0/en/Celularity-Appoints-Geoffrey-Shiu-Fei-Ling-M-D-Ph-D-to-its-Board-of-Directors.html
 Bullish
Macroaxis News: globenewswire.com
Celularity Announces Multi-Year Research Collaboration Services Agreement With Regeneron
https://www.globenewswire.com/news-release/2023/08/29/2733451/0/en/Celularity-Announces-Multi-Year-Research-Collaboration-Services-Agreement-With-Regeneron.html
 Neutral
Macroaxis News: globenewswire.com
Celularity Inc. Announces $3 Million Registered Direct Offering
https://www.globenewswire.com/news-release/2023/07/27/2712276/0/en/Celularity-Inc-Announces-3-Million-Registered-Direct-Offering.html
 Neutral
Macroaxis News: globenewswire.com
Celularity and Verséa Ophthalmics Announ...
https://www.globenewswire.com/news-release/2023/07/27/2712254/0/en/Celularity-and-Vers%C3%A9a-Ophthalmics-Announce-Exclusive-U-S-Commercialization-Agreement-to-Distribute-Biovance-and-Biovance-3l-Ocular-For-Ophthalmic-Applications.html
 Bullish
Macroaxis News: globenewswire.com
(SPAC) Special Purpose Acquisition Investigation: FFIE, NRGV, CELU, EMBK Contact Shareholder Rights Law Firm Johnson Fistel
https://www.globenewswire.com/news-release/2023/07/21/2709086/0/en/SPAC-Special-Purpose-Acquisition-Investigation-FFIE-NRGV-CELU-EMBK-Contact-Shareholder-Rights-Law-Firm-Johnson-Fistel.html
 Bullish
Macroaxis News: globenewswire.com
Celularity Human Placental-Derived Advan...
https://www.globenewswire.com/news-release/2023/07/18/2706479/0/en/Celularity-Human-Placental-Derived-Advanced-Biomaterials-Demonstrate-Superior-Biocompatibility-and-Better-Support-Differentiated-Cell-Functions-in-Studies.html
 Neutral
Macroaxis News: globenewswire.com
(SPAC) Special Purpose Acquisition Investigation: FFIE, NRGV, CELU, Contact Shareholder Rights Law Firm Johnson Fistel
https://www.globenewswire.com/news-release/2023/07/12/2703728/0/en/SPAC-Special-Purpose-Acquisition-Investigation-FFIE-NRGV-CELU-Contact-Shareholder-Rights-Law-Firm-Johnson-Fistel.html
 Bullish

Celularity Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Celularity and other traded companies coverage with news coverage. We help investors stay connected with Celularity headlines for the 24th of November to make an informed investment decision based on correlating the impacts of news items on Celularity Stock performance. Please note that trading solely based on the Celularity hype is not for everyone as timely availability and quick action are needed to avoid losses.
Celularity's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Celularity investors visualize upcoming and past events in order to time the market based on Celularity noise-free hype analysis.
Celularity stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Celularity earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Celularity that are available to investors today. That information is available publicly through Celularity media outlets and privately through word of mouth or via Celularity internal channels. However, regardless of the origin, that massive amount of Celularity data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Celularity news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Celularity relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Celularity's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Celularity alpha.

Celularity Largest EPS Surprises

Earnings surprises can significantly impact Celularity's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-05-22
2023-03-31-0.24-0.41-0.1770 
2022-05-16
2022-03-31-0.26-0.48-0.2284 
2023-08-14
2023-06-30-0.03-0.27-0.24800 
2022-03-31
2021-12-31-0.31-0.030.2890 
2022-11-10
2022-09-30-0.260.030.29111 
2023-12-05
2023-09-30-0.03-0.4985-0.46851561 
View All Earnings Estimates

Celularity Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Celularity Stock. Current markets are strongly bullish. About 86% of major world exchanges and indexes are currently up. See today's market update for more information.
Google News at Macroaxis
20th of November 2024
Celularity Partners with Genting to Build 7.2B Market-Targeting Stem Cell Facility in Bali...
at news.google.com 
Macroaxis News: globenewswire.com
7th of November 2024
Celularity Raises Full Year 2024 Guidance asExpected Net Sales Through October Reach 44.4 ...
at globenewswire.com 
Yahoo News
22nd of October 2024
Celularity Provides Corporate Update
at finance.yahoo.com 
Yahoo News
18th of October 2024
Celularity Inc. Receives Notice from Nasdaq Confirms Intention to File an Appeal
at finance.yahoo.com 
Macroaxis News: globenewswire.com
16th of October 2024
Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of R...
at globenewswire.com 
Google News at Macroaxis
2nd of October 2024
Celularity Stock Price Down 8.8 percent - Should You Sell - MarketBeat
at news.google.com 
Yahoo News
5th of September 2024
Celularity to Present at H.C. Wainwrights 26th Annual Global Investment Conference
at finance.yahoo.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Celularity in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Celularity's short interest history, or implied volatility extrapolated from Celularity options trading.

Additional Tools for Celularity Stock Analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.